Physician profile
Jordan E Praytor
NPI 1518238666
$1,638.04
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $409 · 2022: $366 · 2023: $145 · 2024: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $718 · Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $717.50 |
| Food and Beverage | $145.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $717.50 | 2024 | |
| Abbvie INC. | $416.91 | 2021-2023 | |
| Janssen Biotech, INC. | $136.89 | 2021-2023 | Stelara, Remicade, Simponi Aria |
| E.R. Squibb & Sons, L.L.C. | $87.82 | 2022-2023 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $80.99 | 2021 | |
| Incyte Corporation | $54.40 | 2021 | |
| Pfizer INC. | $34.89 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.64 | 2022 | |
| Ucb, INC. | $19.61 | 2021 | |
| Lilly USA, LLC | $19.05 | 2022 | |
| Galderma Laboratories, L.P. | $17.21 | 2023 | |
| Helsinn Therapeutics (U.S.), INC. | $16.18 | 2021 | |
| Medtronic, INC. | $12.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Praytor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.